UBS Reiterates Neutral Rating on Carter's (CRI)

July 8, 2026 9:39 AM

UBS analyst Jay Sole reiterated a Neutral rating and $41.00 price target on Carter's (NYSE: CRI).The analyst commented, "Our checks ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found